The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling

American Journal of Pathology

Volumn 177, Issue 4, 2010, Pages 1710-1724

  Sweetwyne, Mariya T ^a   Pallero, Manuel A ^b   Lu, Ailing ^b   Van Duyn Graham, Lauren ^b,c   Murphy Ullrich, Joanne E ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; COLLAGEN; ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN KINASE B INHIBITOR; SMAD PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SURGICAL SPONGE;

EID: 77957357565     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090903     Document Type: Article

References (70)

1. Midwood KS, Williams LV, Schwarzbauer JE: Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004, 36:1031-1037
2. Alford AI, Hankenson KD: Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 2006, 38:749-757 (Pubitemid 44498588)
3. Schellings MW, Pinto YM, Heymans S: Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res 2004, 64:24-31
4. McPherson J, Sage H, Bornstein P: Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin. J Biol Chem 1981, 256:11330-11336 (Pubitemid 12219997)
5. Raugi GJ, Mumby SM, Ready CA, Bornstein P: Location and partial characterization of the heparin-binding fragment of platelet thrombospondin. Thromb Res 1984, 36:165-175 (Pubitemid 14020861)
6. DiPietro LA, Polverini PJ: Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am J Pathol 1993, 143:678-684
7. Reed MJ, Iruela-Arispe L, O'Brien ER, Truong T, LaBell T, Bornstein P, Sage EH: Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. Am J Pathol 1995, 147:1068-1080
8. Majack RA, Cook SC, Bornstein P: Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci USA 1986, 83:9050-9054
9. Agah A, Kyriakides TR, Lawler J, Bornstein P: The lack of thrombospondin- 1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002, 161:831-839 (Pubitemid 34988370)
10. Murphy-Ullrich JE, Hook M: Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol 1989, 109:1309-1319
11. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 1993, 122:923-932 (Pubitemid 23241101)
12. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD: CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 2006, 281:26069-26080
13. Ferrari do Outeiro-Bernstein MA, Nunes SS, Andrade AC, Alves TR, Legrand C, Morandi V: A recombinant NH(2)-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan. Matrix Biol 2002, 21:311-324
14. Iruela-Arispe ML, Bornstein P, Sage H: Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991, 88:5026-5030 (Pubitemid 21914676)
15. Pallero MA, Elzie CA, Chen J, Mosher DF, Murphy-Ullrich JE: Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J 2008, 22:3968-3979
16. Adams JC, Kureishy N, Taylor AL: A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1. J Cell Biol 2001, 152:1169-1182 (Pubitemid 34280175)
17. Chung J, Wang XQ, Lindberg FP, Frazier WA: Thrombospondin-1 acts via IAP/CD47 to synergize with collagen in alpha2beta1-mediated platelet activation. Blood 1999, 94:642-648 (Pubitemid 29323878)
18. Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, Bouck NP: CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 1997, 138:707-717 (Pubitemid 27349849)
19. Orr AW, Pedraza CE, Pallero MA, Elzie CA, Goicoechea S, Strickland DK, Murphy-Ullrich JE: Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J Cell Biol 2003, 161:1179-1189 (Pubitemid 36870178)
20. Goicoechea S, Orr AW, Pallero MA, Eggleton P, Murphy-Ullrich JE: Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J Biol Chem 2000, 275:36358-36368
21. Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T, Iruela-Arispe L, Detmar M: Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 2000, 19:3272-3282 (Pubitemid 30428205)
22. Isenberg JS, Calzada MJ, Zhou L, Guo N, Lawler J, Wang XQ, Frazier WA, Roberts DD: Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor. Matrix Biol 2005, 24:110-123 (Pubitemid 40693635)
23. Iruela-Arispe ML: Regulation of thrombospondin1 by extracellular proteases. Curr Drug Targets 2008, 9:863-868
24. Lee NV, Sato M, Annis DS, Loo JA, Wu L, Mosher DF, Iruela-Arispe ML: ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J 2006, 25:5270-5283
25. Murphy-Ullrich JE, Gurusiddappa S, Frazier WA, Hook M: Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J Biol Chem 1993, 268:26784-26789
26. Orr AW, Pallero MA, Murphy-Ullrich JE: Thrombospondin stimulates focal adhesion disassembly through Gi- and phosphoinositide 3-kinase-dependent ERK activation. J Biol Chem 2002, 277:20453-20460
27. Orr AW, Pallero MA, Xiong WC, Murphy-Ullrich JE: Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly. J Biol Chem 2004, 279:48983-48992
28. Murphy-Ullrich JE: The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest 2001, 107:785-790
29. Orr AW, Elzie CA, Kucik DF, Murphy-Ullrich JE: Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J Cell Sci 2003, 116:2917-2927
30. Yan Q, Murphy-Ullrich JE, Song Y: Structural insight into the role of thrombospondin-1 binding to calreticulin in calreticulin-induced focal adhesion disassembly. Biochemistry 2010, 49:3685-3694
31. Goicoechea S, Pallero MA, Eggleton P, Michalak M, Murphy-Ullrich JE: The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin. J Biol Chem 2002, 277:37219-37228
32. Murphy-Ullrich JE, Schultz-Cherry S, Hook M: Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell 1992, 3:181-188
33. Bonadio J, Smiley E, Patil P, Goldstein S: Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999, 5:753-759
34. Midwood KS, Wierzbicka-Patynowski I, Schwarzbauer JE: Preparation and analysis of synthetic multicomponent extracellular matrix. Methods Cell Biol 2002, 69:145-161
35. Van Duyn Graham L, Sweetwyne MT, Pallero MA, Murphy-Ullrich JE: Intracellular calreticulin regulates multiple steps in fibrillar collagen expression, trafficking, and processing into the extracellular matrix. J Biol Chem 2010, 285:7067-7078
36. Hedman K, Kurkinen M, Alitalo K, Vaheri A, Johansson S, Hook M: Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol 1979, 81:83-91
37. Taipale J, Miyazono K, Heldin CH, Keski-Oja J: Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 1994, 124:171-181
38. Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, Sebti SM, Cheng JQ: Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 2004, 64:4394-4399
39. Zhou Y, Hagood JS, Murphy-Ullrich JE: Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol 2004, 165:659-669
40. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1994, 216:276-284
41. Carlson CB, Lawler J, Mosher DF: Structure of Thrombospondins. Cell Mol Life Sci 2008, 65:672-686
42. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE: Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 1994, 269:26775-26782
43. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, et al.: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986, 83:4167-4171
44. Greenwood JA, Pallero MA, Theibert AB, Murphy-Ullrich JE: Thrombospondin signaling of focal adhesion disassembly requires activation of phosphoinositide 3-kinase. J Biol Chem 1998, 273:1755-1763
45. Nor JE, DiPiertro L, Murphy-Ullrich JE, Hynes RO, Lawler J, Polverini PJ: Activation of latent TGF-beta by thrombospondin-1 is a major component of wound repair. Oral Biosci Med 2005, 2:153-161
46. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P: Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 1998, 140:419-430
47. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ: Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 1996, 148:1851-1860
48. Zhou L, Isenberg JS, Cao Z, Roberts DD: Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin- 1. Oncogene 2006, 25:536-545
49. Moura R, Tjwa M, Vandervoort P, Cludts K, Hoylaerts MF: Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation. Arterioscler Thromb Vasc Biol 2007, 27:2163-2169
50. Nor JE, DiPietro L, Murphy-Ullrich JE, Hynes RO, Lawler J, Polverini PJ: Activation of latent TGF-beta 1 by thrombospondin-1 is a major component of wound repair. Oral Biosci Med 2005, 213:153-161
51. Kyriakides TR, Hartzel T, Huynh G, Bornstein P: Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery. Mol Ther 2001, 3:842-849
52. Chuang-Tsai S, Sisson TH, Hattori N, Tsai CG, Subbotina NM, Hanson KE, Simon RH: Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. Am J Pathol 2003, 163:445-452
53. Bradshaw AD, Reed MJ, Carbon JG, Pinney E, Brekken RA, Sage EH: Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice. Wound Repair Regen 2001, 9:522-530 (Pubitemid 34266733)
54. Konttinen YT, Li TF, Michelsson O, Xu JW, Sorsa T, Santavirta S, Imai S, Virtanen I: Expression of tenascin-C in aseptic loosening of total hip replacement. Ann Rheum Dis 1998, 57:619-623 (Pubitemid 28513141)
55. Murphy-Ullrich JE, Lane TF, Pallero MA, Sage EH: SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. J Cell Biochem 1995, 57:341-350
56. Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Hook M: Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 1991, 115:1127-1136 (Pubitemid 21909959)
57. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE: The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem 1994, 269:26783-26788 (Pubitemid 24332872)
58. Bujor AM, Pannu J, Bu S, Smith EA, Muise-Helmericks RC, Trojanowska M: Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol 2008, 128:1906-1914 (Pubitemid 352001221)
59. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K: Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol 2004, 172:7123-7135
60. Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, Scanga A, Brenner DA, Rippe RA: The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 2003, 278:8083-8090 (Pubitemid 36800548)
61. Ricupero DA, Poliks CF, Rishikof DC, Cuttle KA, Kuang PP, Goldstein RH: Phosphatidylinositol 3-kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol 2001, 281:C99-C105
62. Runyan CE, Schnaper HW, Poncelet AC: The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 2004, 279:2632-2639
63. Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, Michalak M, Murphy-Ullrich JE: Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010, 24:665-683
64. Wu X, Liu X, Zhu X, Tang C: Hypoxic preconditioning induces delayed cardioprotection through p38 MAPK-mediated calreticulin upregulation. Shock 2007, 27:572-577 (Pubitemid 46626085)
65. Kypreou KP, Kavvadas P, Karamessinis P, Peroulis M, Alberti A, Sideras P, Psarras S, Capetanaki Y, Politis PK, Charonis AS: Altered expression of calreticulin during the development of fibrosis. Proteomics 2008, 8:2407-2419
66. Milner RE, Baksh S, Shemanko C, Carpenter MR, Smillie L, Vance JE, Opas M, Michalak M: Calreticulin, and not calsequestrin, is the major calcium binding protein of smooth muscle sarcoplasmic reticulum and liver endoplasmic reticulum. J Biol Chem 1991, 266:7155-7165
67. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK: LDL receptor- related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 2008, 88:887-918
68. Chen H, Sottile J, Strickland DK, Mosher DF: Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1. Biochem J 1996, 318:959-963 (Pubitemid 26320965)
69. Hogg PJ, Owensby DA, Chesterman CN: Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. Determination of the kinetic mechanism of inhibition and localization of cathepsin G binding to the thrombospondin 1 type 3 repeats. J Biol Chem 1993, 268:21811-21818
70. Hogg PJ, Jimenez BM, Chesterman CN: Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase. Biochemistry 1994, 33:6531-6537